JP2023515665A5 - - Google Patents

Info

Publication number
JP2023515665A5
JP2023515665A5 JP2022552541A JP2022552541A JP2023515665A5 JP 2023515665 A5 JP2023515665 A5 JP 2023515665A5 JP 2022552541 A JP2022552541 A JP 2022552541A JP 2022552541 A JP2022552541 A JP 2022552541A JP 2023515665 A5 JP2023515665 A5 JP 2023515665A5
Authority
JP
Japan
Prior art keywords
snps
snp
assayed
reagent
specific portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022552541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/019265 external-priority patent/WO2021178166A1/en
Publication of JP2023515665A publication Critical patent/JP2023515665A/ja
Publication of JP2023515665A5 publication Critical patent/JP2023515665A5/ja
Pending legal-status Critical Current

Links

JP2022552541A 2020-03-06 2021-02-23 神経伝達物質トランスポーターの阻害剤の有効性を評価するための組成物及び方法 Pending JP2023515665A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062986603P 2020-03-06 2020-03-06
US62/986,603 2020-03-06
PCT/US2021/019265 WO2021178166A1 (en) 2020-03-06 2021-02-23 Compositions and methods for assessing the efficacy of inhibitors of neurotransmitter transporters

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026065220A Division JP2026133377A (ja) 2020-03-06 2026-04-10 神経伝達物質トランスポーターの阻害剤の有効性を評価するための組成物及び方法

Publications (2)

Publication Number Publication Date
JP2023515665A JP2023515665A (ja) 2023-04-13
JP2023515665A5 true JP2023515665A5 (enExample) 2024-03-05

Family

ID=77613738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022552541A Pending JP2023515665A (ja) 2020-03-06 2021-02-23 神経伝達物質トランスポーターの阻害剤の有効性を評価するための組成物及び方法

Country Status (13)

Country Link
US (1) US12612661B2 (enExample)
EP (1) EP4106872B1 (enExample)
JP (1) JP2023515665A (enExample)
KR (1) KR20230005816A (enExample)
CN (1) CN115515680A (enExample)
AR (1) AR121515A1 (enExample)
AU (1) AU2021231683A1 (enExample)
BR (1) BR112022017770A2 (enExample)
CA (1) CA3174572A1 (enExample)
IL (1) IL296168A (enExample)
MX (1) MX2022010816A (enExample)
TW (1) TW202146660A (enExample)
WO (1) WO2021178166A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000019303A1 (it) * 2020-08-05 2022-02-05 Univ Degli Studi Di Brescia Analoghi strutturali del metilfenidato come agenti disease-modifying della malattia di parkinson
CN114848835B (zh) * 2022-03-22 2023-08-25 暨南大学 塞来昔布的聚乙二醇修饰及连接叶酸基团的靶向药物分子及制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6945457B1 (en) * 1996-05-10 2005-09-20 Transaction Holdings Ltd. L.L.C. Automated transaction machine
JP4198582B2 (ja) * 2003-12-02 2008-12-17 独立行政法人科学技術振興機構 タンタルオキシナイトライド酸素還元電極触媒
WO2007128884A1 (en) * 2006-05-09 2007-11-15 Oy Jurilab Ltd Novel genes and markers in type 2 diabetes and obesity
US20080299125A1 (en) 2006-06-05 2008-12-04 Perlegen Sciences, Inc. Genetic basis of treatment response in depression patients
WO2008065544A2 (en) * 2006-09-11 2008-06-05 Mcgill University Genetic predictors of risk for type 2 diabetes mellitus
AU2008222563A1 (en) 2007-03-05 2008-09-12 Cancer Care Ontario Assessment of risk for colorectal cancer
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US20170029892A1 (en) * 2009-05-29 2017-02-02 Jay L. Lombard Methods and compositions for the treatment of post-traumatic stress disorder
MX2013008846A (es) 2011-01-31 2014-02-11 Denovo Biomarkers Inc Metodo para descubrir biomarcadores farmacogenomicos.
WO2012156515A1 (en) * 2011-05-18 2012-11-22 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of acute myeloid leukemia
US10202652B2 (en) 2011-06-08 2019-02-12 Denovo Biopharma (Hangzhou) Ltd. Co. Methods and compositions of predicting activity of retinoid X receptor modulator
US20140274764A1 (en) 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to treatments for mental disorders
US20170253928A1 (en) * 2013-03-15 2017-09-07 Pathway Genomics Corporation Method and system to predict response to treatments for mental disorders
PL3117012T5 (pl) * 2014-03-14 2026-03-16 Caredx, Inc. Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu

Similar Documents

Publication Publication Date Title
Dickel et al. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder
Rahman et al. Polymerase chain reaction (PCR): a short review
US20210054457A1 (en) Autism associated genetic markers
JP2012235778A (ja) アセトアルデヒド脱水素酵素2及びアルコール脱水素酵素2の遺伝子変異を同時に検出する方法
RU2018122965A (ru) Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания
Yang et al. The source of SYBR green master mix determines outcome of nucleic acid amplification reactions
US20140220567A1 (en) Discrimination of blood type variants
KR102158716B1 (ko) Arhgap32 유전자의 단일염기다형성을 포함하는 뇌동맥류 진단용 snp 마커
JP2013074888A (ja) IL28B(rs8099917)とITPA(rs1127354)の変異を検出する方法
Abdollahi et al. Homogeneous assay of rs4343, an ACE I/D proxy, and an analysis in the British Women’s Heart and Health Study (BWHHS)
AU2011315926B2 (en) Quantitative multiplexed identification of nucleic acid targets
Sjöroos et al. Time‐resolved fluorometry based sandwich hybridisation assay for HLA‐DQA1 typing
CN104293968B (zh) 一组用于检测非综合征性唇腭裂遗传易感性的多态性位点及检测试剂盒
JP2010508029A (ja) 抗うつ薬による治療時に有害事象を発現する危険性のある患者の識別方法
JP2010508029A5 (enExample)
Papanikos et al. Lateral flow dipstick test for genotyping of 15 beta-globin gene (HBB) mutations with naked-eye detection
Sebastian et al. Integrated amplification microarray system in a lateral flow cell for warfarin genotyping from saliva
EP2471949A1 (en) Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W)
KR102268059B1 (ko) 운동 민감도 예측용 조성물, 키트, 및 이를 이용한 방법
US11225684B2 (en) Method and device for SNP genotyping
KR102879756B1 (ko) 이상지질혈증 예측 또는 진단용 snp 마커 및 이의 용도
RU2675324C1 (ru) Способ определения в гене галактозо-1-фосфатуридилтрансферазы человека мутации q188r, rs75391579
KR102511596B1 (ko) 단일염기다형성을 이용한 안지오텐신 전환효소억제제 이상반응 진단용 조성물 및 이를 이용한 방법
JP2012000081A (ja) Snpによる肥満化のリスクの予測
KR20200066946A (ko) 식습관 민감도 예측용 조성물, 키트, 및 이를 이용한 방법